IRIS
PORRECA, Ettore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.218
EU - Europa 4.650
AS - Asia 1.912
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 9
AF - Africa 6
SA - Sud America 4
Totale 11.811
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.192
CN - Cina 1.002
UA - Ucraina 944
IE - Irlanda 911
SE - Svezia 773
TR - Turchia 643
IT - Italia 576
GB - Regno Unito 524
FR - Francia 333
DE - Germania 310
IN - India 189
FI - Finlandia 175
BE - Belgio 31
CA - Canada 23
TW - Taiwan 17
RU - Federazione Russa 16
VN - Vietnam 14
EU - Europa 11
PL - Polonia 10
AU - Australia 8
GR - Grecia 8
KR - Corea 8
NL - Olanda 8
IL - Israele 7
IR - Iran 7
HK - Hong Kong 6
RO - Romania 6
ES - Italia 5
TH - Thailandia 5
ID - Indonesia 4
JP - Giappone 4
AT - Austria 3
KE - Kenya 3
BD - Bangladesh 2
BR - Brasile 2
DK - Danimarca 2
EE - Estonia 2
EG - Egitto 2
HR - Croazia 2
MX - Messico 2
NO - Norvegia 2
RS - Serbia 2
SR - Suriname 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BY - Bielorussia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
HU - Ungheria 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PR - Porto Rico 1
SG - Singapore 1
ZA - Sudafrica 1
Totale 11.811
Salva come PNG Salva come JPEG
Città #
Chandler 1.116
Jacksonville 1.082
Dublin 896
Princeton 451
Southend 403
Izmir 345
Nanjing 303
Dearborn 251
Wilmington 229
Cambridge 177
Ashburn 165
Beijing 154
Altamura 142
Ann Arbor 132
Chieti 126
Nanchang 100
Woodbridge 81
Boardman 72
Hebei 66
Shenyang 55
Kunming 48
Jiaxing 45
Tianjin 43
New York 37
Grevenbroich 33
Washington 33
Los Angeles 31
Brussels 29
Hangzhou 28
Changsha 27
San Mateo 27
Norwalk 26
Houston 25
Falls Church 24
Pescara 22
Jinan 20
Leawood 20
Seattle 20
Augusta 18
Orange 17
Helsinki 16
Guangzhou 15
Dong Ket 14
Ningbo 14
Toronto 14
Auburn Hills 12
Hefei 12
Kocaeli 12
Teramo 11
Hanover 10
Kraków 10
Lanzhou 10
Changchun 9
Bellante 8
Edinburgh 8
Montenero Di Bisaccia 8
Rome 8
Taizhou 8
Zhengzhou 8
Cologno Monzese 7
Monmouth Junction 7
San Giovanni 7
Sant'onofrio 7
Taipei 7
Vasto 7
Ardabil 6
Pianella 6
Sydney 6
Tappahannock 6
Bangkok 5
Buffalo 5
Pune 5
Rochester 5
Altino 4
Fuzhou 4
Haikou 4
Hong Kong 4
Mcallen 4
Milan 4
Montesilvano Marina 4
New Taipei 4
Plymouth 4
Redmond 4
Redwood City 4
Trieste 4
Amsterdam 3
Andover 3
Bangalore 3
Düsseldorf 3
Gangbuk-gu 3
Iglesias 3
Loreto Aprutino 3
Madrid 3
Marseille 3
Mumbai 3
Nairobi 3
Norfolk 3
Oxford 3
Paris 3
Pirri 3
Totale 7.305
Salva come PNG Salva come JPEG
Nome #
Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort Study 187
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. 108
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 104
Reduced variability to aspirin antiplatelet effect by the coadministration of statins in high-risk patients for cardiovascular disease. 99
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy 95
48-Hour continuous pH measurement in patients with gastro-oesophageal reflux: effect of cisapride. 94
Ambulatory Blood Pressure Parameters and Heart Failure With Reduced or Preserved Ejection Fraction in Elderly Treated Hypertensive Patients 92
Effect of MK-571, a selective leukotriene D4 receptor antagonist, on vascular smooth muscle cell proliferation and interleukin 1 release 90
INCREASED TYPE I AND TYPEII TRANSFORMING GROWTH FACTOR-β RECEPTOR EXPRESSION DURING CHOLESTEROL CHALLENGE. 88
Pravastatin upregulates TGF-b1 in THP-1 human macrophage: effect on scavenger receptor class A expression. 87
Haemostatic abnormalities, cardiac involvement and serum tumor necrosis factor levels in X-linked dystrophic patients. 85
Reversal of P-glycoprotein-mediated multidrug resi stance in human sarcoma MES-SA/Dx-5 cells by nonsteroidal anti-inflammatory drugs 83
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry 83
Impaired enzymatic reactive aldehyde-detoxifying capacity and glutathione peroxidase activity in the aged human arterial tissue 83
ISOXAZOLE DERIVATIVES AND THEIR USE AS CYCLOOXYGENASE INHIBITORS 82
Apixaban for extended treatment of venous thromboembolism 82
Aortic antioxidant defence mechanisms: time-related changes in cholesterol-fed rabbits. 81
Prognostic value of nondipping and morning surge in elderly treated hypertensive patients with controlled ambulatory blood pressure 81
Increased expression of transforming growth factor beta isoforms by human monocytes of hypertensive patients 81
Circadian variations in antioxidant defences and lipid peroxidation in the rat heart 79
Study of the gastric mucosal reactivity in patients with urticaria induced by nonsteroidal anti-inflammatory drugs. 79
Inhibition of P-glycoprotein-mediated multidrug resistance by unfractionated heparin: a new potential chemosensitizer for cancer therapy. 78
Cholesterol feeding modulates type I and type II TGF-beta receptor expression and fibrogenic vascular remodelling in C57BL/6 mice (pubbl. su Atherosc.) 77
Synergic effect of glucose and insulin in stimulating plasminogen activator inhibitor 1 (PAI-1) expression and secretion in human vascular smooth cells (vSMC) 77
Angiotensin-converting enzyme inhibitors counteract hypoxia-induced coronary constriction in the isolated rat heart 76
Reduced thromboxane biosynthesis in carriers of toll-like receptor 4 polymorphisms in vivo. 76
Transforming growth factor beta1 induces IL-1 receptor antagonist production and gene expression in rat vascular smooth muscle cells 76
Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review 76
Antioxidant metabolic mechanisms in hypertensive and atherosclerotic arterial wall 76
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism 76
PRAVASTATIN UP-REGULATES TGF-B1 IN THP-1 HUMAN MACROPHAGES :EFFECT ON SCAVENGER RECEPTOR CLASS A EXPRESSION 74
Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. 74
CYCLOOXYGENASE-2-DERIVED PROSTACYCLIN RESTRAIN PLATELET THROMBOXANE BIOSYNTHESIS IN TOLL-LIKE RECEPTOR 4 POLYMORPHISM 74
The effect of the plasticizer diethylhexyl phthalate on transport activity and expression of P-glycoprotein in parental and doxo-resistant human sarcoma cell lines. 74
Oral apixaban for the treatment of acute venous thromboembolism 74
Transforming growth factor beta1 induces IL-1 receptor antagonist gene expression and production in rat vascular smooth muscle cells 73
Increased Plasminogen Activator Inhibitor (PAI-1) Synthesis and Gene Expression in Adipocyte of Diabetic Rats 73
New method for the extraction of DNA from white blood cells for the detection of common genetic variants associated with thrombophilia 73
Effect of ischemia and reperfusion on antioxidant enzymes and mitochondrial inner membrane proteins in perfused rat heart. 73
Antiproliferative effect of deferoxamine on vascular muscle cells in vitro and in vivo. 73
AORTIC ANTIOXIDANT DEFENSE MECHANISMS IN RABBITS SUBJECTED TO SUPRARENAL AORTIC COARCTATION HYPERTENSION 73
Oral rivaroxaban for symptomatic venous thromboembolism 73
Increased type II transforming growth factor-beta receptor expression in liver cells during cholesterol challenge 72
The hematocrit and platelet target in polycytemia vera 72
Morning Blood Pressure Surge, Dipping, and Risk of Coronary Events in Elderly Treated Hypertensive Patients 72
Iron status and oxidative stress in the aged rabbit heart 72
Monocyte chemotactic protein 1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells. 71
Aortic antioxidant defence mechanisms during the progression of atherosclerosis in cholesterol-fed rabbits 71
Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta-analysis 71
Monocyte chemoattractant protein-1 as a mitogen for vascular smooth muscle cell 70
Myocardial antioxidant defence mechanisms: time-related changes after reperfusion of the ischemic rat heart 70
Antioxidant metabolic mechanisms in hypertensive and atherosclerotic arterial wall 70
Circadian blood pressure changes and cardiovascular risk in elderly-treated hypertensive patients 70
Dementia in patients with atrial fibrillation and the value of the Hachinski ischemic score 70
Arterial Thrombosis in ambulatory cancer patients treated with chemotherapy. 70
Combined effect of glucose and insulin in stimulating plasminogen activator inhibitor-1 secretion and gene expression in human vascular smooth muscle cells in culture 69
Metabolic Syndrome and Cardiovascular Risk in Elderly Treated Hypertensive Patients. 69
Regional distribution of glutathione-related antioxidant defences in the normal rabbit aorta. 68
Association of Factor VII Levels With Inflammatory Parameters in Hypercholesterolemic Patients. 68
Soluble thrombomodulin and vascular adhesion molecule-1 are associated to leptin plasma levels in obese patients. 68
Antioxidant properties of ticlopidine on human low density lipoprotein oxidation 68
Current management strategies and long-term clinical outcomes of upper extremity venous thrombosis 68
Systemic oxidative stress status in patients with ischemic heart disease 67
Vascular changes in hypertensive patients with different left ventricular geometry 66
Glutathione-related enzyme activities and lipoperoxide levels in human internal mammary artery and ascending aorta. Relations with serum lipids 66
Prognosis of Masked and White Coat Uncontrolled Hypertension Detected by Ambulatory Blood Pressure Monitoring in Elderly Treated Hypertensive Patients 66
Down regulation of cyclooxygenase-2 (COX-2) by interleukin-1 receptor antagonist in human monocytes. 65
Infra-red laser irradiation enhances interleukin-1 receptor antagonist, increase 3H-thymidine incorporation and the release of 3H arachidonic acid in human macrophages 65
Modulatory effects of heparin on cellular accumulation and cytotoxicity of doxorubicin in MRP1-overexpressing HL60/doxo cells. 65
Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis 65
Rivaroxaban for cancer-associated cardiac thrombosis 65
Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients 65
Human interleukin 1 receptor antagonist (IL-1RA) inhibition of inducible thromboxane B2 generation in human monocytes 65
Effect of interleukin-1 receptor antagonist (IL-1RA) on vascular smooth muscle cell proliferation (VSMC). 64
Microsatellite polymorphism of the human leptin gene (LEP) and risk of cardiovascular disease 64
Increased transforming growth factor-beta production and gene expression by peripheral blood monocytes of hypertensive patients. 64
Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy 64
Aortic glutathione-related antioxidant defences in rabbits subjected to suprarenal aortic coarctation hypertension 64
Cysteinyl-leukotriene D4 induced IL-1 beta expression ans release in rat vascular smooth muscle cells. 64
Changes in the myocardial enzymatic systems (AES) induced by ischemia-reperfusion in the isolated rat heart 64
Effects of toll-like receptor-4 gene polymorphisms on soluble P-selectin and von Willebrand factor levels in hypercholesterolemic patients. 63
Induction of alkaline phosphatase generation by IL-1ß and LPS on human neutrophils and macrophages and lack of inhibition by interleukin-1 receptor antagonist. 63
Identification of three genetic risk factors for venous thrombosis using a multiplex allele-specific PCR assay: comparison of conventional and new alternative methods for the preparation of DNA from clinical samples 63
Circulating leptin is associated with oxidized LDL in postmenopausal women. 63
Modulation of aspirin-insensitive eicosanoid biosynthesis by 6-methylprednisolone in unstable angina. 63
Determinants of platelet activation in Alzheimer's disease 63
Protein kinase C pathway and proliferative response of aged and young rat vascular smooth muscle cell. 62
Vascular non-protein thiols: prooxidants or antioxidants in atherogenesis? 62
Increased phosphatidylserine exposure on platelets from hospitalized patients with acute medical illnesses 62
Effect of aortic coarctation hypertension on the antioxidant defense mechanisms in the rabbit aorta 62
Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy. 62
Superior vena cava syndrome from an intracardiac non-Hodgkin lymphoma. 61
THE ROLE OF VASOACTIVE AUTACOIDS IN SERUM-INDUCED VASCULAR SMOOTH MUSCLE CELL PROLIFERATION. 61
Human recombinant interleukin-1 beta induces thromboxane A2 release in polymorphonuclear leukocytes, macrophages and platelets: effect of IL-1 receptor antagonist. 61
Effects of multiple inherited and acquired thrombophilia on outcomes of in-vitro fertilization 61
EFFECTS OF NABUMETONE AND ITS ACTIVE METABOLITE 6-METHOXY-2-NAPHTHYL ACETIC ACID ON HUMAN BLOOD PROSTAGLANDIN H SYNTHASES. 60
Asymptomatic venous thromboembolism in patients with solid tumors treated with chemotherapy: An underestimated phenomenon 60
The diagnostic management of upper extremity deep vein thrombosis: A review of the literature 60
Trasforming growth factor-beta 1 levels in hypertensive patients: association with body mass index and leptin. 59
Extended Use of dabigatran, warfarin, or placebo in venous thromboembolism 59
Totale 7.309
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.123
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.123
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019448 0 0 0 0 0 0 0 0 0 0 10 438
2019/20202.471 764 172 25 82 191 189 335 221 72 157 241 22
2020/20211.314 178 17 229 26 110 275 15 20 101 170 79 94
2021/20221.065 53 14 14 247 81 24 27 85 69 17 107 327
2022/20233.152 268 410 182 336 307 644 181 228 407 39 88 62
2023/20241.253 96 48 124 45 108 401 302 55 31 38 5 0
Totale 12.400